2月5日，葛兰素史克（GSK）公布了2024年财报业绩。数据显示，公司全年营收达到313.76亿英镑（约合401.27亿美元），同比增长7%（按固定汇率计算，下同），展现出业绩强劲增长势头。

GSK’s vaccine portfolio. GSK’s portfolio of more than 20 marketed vaccines, one of the industry’s broadest, protects people against diseases such as meningitis, shingles, polio, measles ...

With Sunday’s Academy Awards ceremony in the rearview mirror, GSK is looking ahead to a potential blockbuster premiere of its own. The British Big Pharma has filed depemokimab for FDA approval ...